ECRI Institute recently reviewed published data on Abiomed's Impella RP (Right Percutaneous) transcatheter ventricular assist device (VAD). The institute said the device provides immediate significant improvements in hemodynamics with considerable short-term and long-term survival rates.

Outcomes from the initial commercial experience of transcatheter mitral valve repair (TMVR) with Abbott's MitraClip were deemed favorable in a late-breaking clinical trial session at the American College of Cardiology's (ACC) 64 th annual scientific session and expo in March.

C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device to remove blood clots from a patient with a cold leg using the Aspire mechanical thrombectomy device.


Cardiac computed tomography angiography (CCTA) is known to have excellent anatomical imaging, but has lacked the ability for functional assessments, requiring chest pain patients with intermediate stenosis lesions to be sent to the cath lab or nuclear myocardial perfusion imaging. However, recent advances in CCTA image analysis software and the accumulation of supporting clinical data may soon enable CT perfusion imaging and virtual fractional flow reserve-CT (FFR-CT) to become mainstream in the coming years.


Biotronik announced the publication of promising clinical results regarding its Pulsar-18 stent platform. Adding to the similarly encouraging data collected in the earlier 4EVER and PEACE trials, the new results — published in Clinical Medical Insights: Cardiology — further confirm the safety and efficacy of the Pulsar-18 self-expanding nitinol stent, with positive patency results for very challenging cases of femoropopliteal disease.

Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-entry catheter in the United States, Europe and Japan. This expands the Cordis Crossing Portfolio for treatment of chronic total occlusions (CTO), a suite of specialty and workhorse solutions designed to support physicians in crossing the most complex lesions.


More than 50 companies and organizations will display their latest products and services at the American Society of Echocardiography's (ASE) 26th Annual Scientific Sessions, June 12-16 at in Boston, Mass. ASE 2015 is the world's premier meeting for cardiovascular ultrasound practitioners, and promises a wealth of cutting-edge education, research, and the latest vendor technology. 


Subscribe Now